Good question. I do not have a concrete valuation as of yet. It all depends on what shakes out as far as the deals are concerned, which other ventures(dispensary, etc) materialize, what the share structure comes in at, how many people hold(and already own), and what type of sentiment the announcements bring in. If I am to guess, and not really crunch numbers nor exaggerate, I think holding a nickel or better is a low ball guess, and running more than a dime or two is very doable as well. We've been walking down on low volume. Running back up to previous highs should be relatively thin as well, minus the occasional sale or loading wall on the ask, and from there, momentum could drive it home. The best indicator will be the book value once transactions close, entities join, SS changes, and numbers are crunched. I'll go out on a limb and say this: Maybe this rockets sky high and maybe it doesn't, but regardless, .005 will be undervalued if the M & A with India Imports goes through, not even mentioning anything else.
News 
Market Data 
Discover 
